Patent · US Active

CCR2 antagonist peptides

US10253087B2 · kind B2 · utility

0Cited by
0References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 1, 2018
Grant dateApr 9, 2019
Priority date
Expiry dateMay 1, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to a peptide useful as a CCR2 non-competitive antagonist peptide.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.